Conference Coverage

Family environment important in early psychosis outcomes


 

FROM SIRS 2020

‘Interesting’ findings

Commenting on the study, Nicole Kozloff, MD, from the child, youth, and emerging adult program at the Centre for Addiction and Mental Health in Toronto, said one limitation of the study is that it’s not clear what care patients received – or who in the family completed the FES.

It is also important to note that “measures of association do not necessarily imply that one factor caused the other factor,” said Dr. Kozloff, who was not involved in the research. “For example, it may be that, among people with bipolar disorder, open expression of conflict in the family can lead to worse functioning, or that worse functioning can lead to more conflict in the family.”

Nevertheless, Dr. Kozloff described the finding of an emerging association between the family environment and functioning over time as “interesting.”

When young people with FEP enter treatment, “they have reached a crisis point and are functioning poorly,” she noted.

“It could be that there is less to differentiate among levels of functioning at treatment entry but, after 2 years, the individuals have separated into those who have been responsive to treatment and are functioning well, and those who continue to have functional challenges. And this is where we start to see a relationship with family environment emerge,” Dr. Kozloff said.

She also agreed with Dr. Verdolini’s take on the findings, and that family psychoeducation “can reduce relapse rates in schizophrenia and the emotional burden on the family.”

“We also know that having family involvement in care is one of the most robust predictors that young people with psychosis will remain engaged in mental health services,” she said.

Teaching families about psychosis and its treatment, about problem-solving and communication skills, and providing support to ensure that family members know how to get help in a crisis, “is a key part of comprehensive early psychosis intervention,” Dr. Kozloff said. “It is good for the patient and good for the family, and allows the clinicians to provide better care.”

Articulates clinical practice findings

Also commenting on the results, Brian O’Donoghue, MD, PhD, senior clinical research fellow at Orygen, the National Centre of Excellence in Youth Mental Health in Melbourne, described the research as important, adding that the study highlights the need for sufficient follow-up.

“It makes sense that the involvement of family over time has a strong impact upon outcome and functioning,” he said in an interview.

“These research findings articulate what we see in clinical practice, so it is good to see that it is captured,” added Dr. O’Donoghue, who was not associated with the study.

He noted that it is common for family involvement to influence outcome, especially if the family is positively involved. “It is invaluable toward their recovery. However, conversely, if there are ongoing family stressors, then this can be a trigger for relapse or lack of improvement.”

Overall, the results “really emphasize that the family needs to be involved in care.”

The Early Psychosis Prevention and Intervention Centre where Dr. O’Donoghue is a consultant psychiatrist offers a psychoeducational course “to inform families about psychosis, treatment, and how they can support their family members.”

“We also have family peer support workers and family therapists, which are essential to the service and for the young person’s recovery,” Dr. O’Donoghue said.

The investigators and Dr. O’Donoghue disclosed no relevant financial relationships. Dr. Kozloff reported receiving research funding from the CAMH Foundation, Brain & Behavior Research Foundation, Canadian Institutes of Health Research, and AFP Innovation Fund; honoraria from Humber River Hospital, the University of Calgary (Alta.), and the Canadian Consortium for Early Intervention in Psychosis; and salary support from Inner City Health Associates.

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

Cognitive-behavioral therapy a standout for better immune function
MDedge Psychiatry
Preventing arrhythmias and QTc prolongation in COVID-19 patients on psychotropics
MDedge Psychiatry
First-episode psychosis in the time of COVID-19
MDedge Psychiatry
Amid pandemic, prison psychiatrists adjust and persist
MDedge Psychiatry
What’s pushing cannabis use in first-episode psychosis?
MDedge Psychiatry
The hidden dangers of supplements: A case of substance-induced psychosis
MDedge Psychiatry
New-onset psychosis while being treated for coronavirus
MDedge Psychiatry
Injectable vs. oral antipsychotics: Which do patients prefer?
MDedge Psychiatry
Potential new biomarker for psychosis severity
MDedge Psychiatry
Community programs improve psychosis outcomes
MDedge Psychiatry